Literature DB >> 1316024

Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway.

K Ueland1, H Lutz.   

Abstract

Serum samples from 224 Norwegian cats were analyzed for the presence of feline leukemia virus (FeLV) p27 common core antigen, and for antibodies to feline immunodeficiency virus (FIV). Ninety specimens originated from the serum bank at the central referral clinic at the Norwegian College of Veterinary Medicine, which had been collected during the years 1983-1989; 67 sera were submitted from veterinarian practitioners; while 67 sera originated from cats presented for euthanasia. The cats were classified into one "healthy" and one "sick" group. Only 2.2% of sick cats and 1.2% of healthy cats showed FeLV antigenemia, a finding which is lower than which has been reported from many other countries. The prevalence of FIV antibodies was 10.1% in sick cats and 5.9% in healthy cats. Antibodies to FIV was most prevalent in male cats (14.7%) than in female cats (2.1%), and more prevalent among domestic cats (12.0%) compared to pedigree cats (2.4%). Antibodies to FIV in the cats demonstrated increasing prevalence with increasing age. It may be concluded that FeLV causes minor problems in Norwegian cats, while FIV is present in a similar prevalence to what is reported from other countries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316024     DOI: 10.1111/j.1439-0450.1992.tb01137.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  7 in total

1.  Feline immunodeficiency virus subtype B in domestic cats in Minas Gerais, Brazil.

Authors:  F A Caxito; F M Coelho; M E Oliveira; M Resende
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

2.  WSAVA Guidelines for the vaccination of dogs and cats.

Authors:  M J Day; M C Horzinek; R D Schultz; R A Squires
Journal:  J Small Anim Pract       Date:  2016-01       Impact factor: 1.522

3.  Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects.

Authors:  A Arjona; E Escolar; I Soto; N Barquero; D Martin; E Gomez-Lucia
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Comparison of risk factors for seropositivity to feline immunodeficiency virus and feline leukemia virus among cats: a case-case study.

Authors:  Bimal K Chhetri; Olaf Berke; David L Pearl; Dorothee Bienzle
Journal:  BMC Vet Res       Date:  2015-02-10       Impact factor: 2.741

Review 5.  Feline immunodeficiency virus infection: an overview.

Authors:  K Hartmann
Journal:  Vet J       Date:  1998-03       Impact factor: 2.688

6.  Epidemiology and clinical outcomes of feline immunodeficiency virus and feline leukaemia virus in client-owned cats in New Zealand.

Authors:  Claire Luckman; M Carolyn Gates
Journal:  JFMS Open Rep       Date:  2017-09-19

7.  Pan-European Study on the Prevalence of the Feline Leukaemia Virus Infection - Reported by the European Advisory Board on Cat Diseases (ABCD Europe).

Authors:  Nadine Studer; Hans Lutz; Claude Saegerman; Enikö Gönczi; Marina L Meli; Gianluca Boo; Katrin Hartmann; Margaret J Hosie; Karin Moestl; Séverine Tasker; Sándor Belák; Albert Lloret; Corine Boucraut-Baralon; Herman F Egberink; Maria-Grazia Pennisi; Uwe Truyen; Tadeusz Frymus; Etienne Thiry; Fulvio Marsilio; Diane Addie; Manfred Hochleithner; Filip Tkalec; Zsuzsanna Vizi; Anna Brunetti; Boyko Georgiev; Louisa F Ludwig-Begall; Flurin Tschuor; Carmel T Mooney; Catarina Eliasson; Janne Orro; Helle Johansen; Kirsi Juuti; Igor Krampl; Kaspars Kovalenko; Jakov Šengaut; Cristina Sobral; Petra Borska; Simona Kovaříková; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2019-10-29       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.